Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.64 |
| ▸ | CA1 | P00915 | 7/20 | 0.64 |
| ▸ | CA9 | Q16790 | 4/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.34 |
| ▸ | CA5A | P35218 | 2/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15254185 | 0.88 | CA2 (0.64) | CA2CA1CA9CA12CA4 | |
| SCHEMBL14441192 | 0.83 | CA2 (0.64) | CA2CA1CA9CA12CA4 | |
| SCHEMBL1847432 | 0.83 | CA2 (0.64) | CA2CA1CA9CA12CA4 | |
| SCHEMBL16307847 | 0.83 | CA2 (0.64) | CA2CA1CA9CA12CA4 | |
| SCHEMBL10883648 | 0.83 | CA2 (0.64) | CA2CA1CA9CA12CA4 | |
| SCHEMBL15254186 | 0.82 | CA2 (0.63) | CA2CA1CA9CA12CA4 | |
| SCHEMBL15254188 | 0.82 | CA2 (0.63) | CA2CA1CA9CA12CA4 | |
| SCHEMBL11520537 | 0.80 | CA2 (0.58) | CA2CA1CA9CA12CA4 | |
| SCHEMBL2672023 | 0.80 | CA2 (0.60) | CA2CA1CA9CA12CA4 | |
| SCHEMBL12408846 | 0.79 | CA2 (0.67) | CA2CA1CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE33000-E | AMINOMONOSACCHARIDE DERIVATIVE | GREENWICH PHARMACEUTICALS, INCORPORATED (US) | 1989-07-25 | — | — | US | disclosed |
| US-RE30379-E | ANTIVIRAL ACTIVITY | STRATEGIC MEDICAL RESEARCH CORP. (US) | 1980-08-19 | — | — | US | disclosed |
| US-4056322-A | Preparation of ethers of monosaccharides | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1977-11-01 | — | — | US | disclosed |
| US-4017608-A | VIRICIDES | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1977-04-12 | — | — | US | disclosed |
| US-3965262-A | OR MEMORY IN WARM BLOODED ANIMALSMONOSACCHARIDE DERIVATIVES | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |
| US-3939146-A | VIRICIDE | STRATEGIC MEDICAL RESEARCH CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |